The human inflammatory response

Journal of Cardiovascular Pharmacology

Volumn 27, Issue SUPPL. 1, 1996, Pages

  Levy, Jerrold H ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Anaphylaxis; Cardiopulmonary bypass; Cytokines; Immune response; Inflammation; Protamine

Indexed keywords

AMINOCAPROIC ACID; APROTININ; CALCIUM; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C5A; CYTOKINE; FREE RADICAL; HEPARIN; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NAFAMSTAT; PROTAMINE SULFATE;

ANAPHYLAXIS; BLOOD CLOTTING; BRONCHOSPASM; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; HYPOTENSION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LUNG ARTERY PRESSURE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RASH; TISSUE INJURY; URTICARIA; VASCULAR ENDOTHELIUM;

EID: 0030047346     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199600001-00008     Document Type: Conference Paper

References (24)

1. Levy JH. Anaphylactic reactions in anesthesia and intensive care, 2nd ed. Boston: Butterworth-Heinemann, 1992:155.
2. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
3. Leonard EJ, Yoshimura T, Tanaka S, Raffield M. Neutrophil recruitment by intradermally injected neutrophil attractant activation protein 1. J Invest Dermatol 1991;96:690-4.
4. Friedman MM, Kaliner M. In situ degranulation of human nasal mucosal mast cells: ultrastructural features and cell-cell associations. J Allergy Clin Immunol 1985;76:70-82.
5. Gomez E, Corrado OJ, Baldwin DL, Swanston AR, Davies RJ. Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man. J Allergy Clin Immunol 1986;78:637-45.
6. Frank MM. Detection of complement in relation to disease. J Allergy Clin Immunol 1992;89:641-52.
7. Tharp MD, Suvunrungsi RT, Sullivan TJ. IgE-mediated release of histamine from human cutaneous mast cells. J Immunol 1983;130:1896-901.
8. Chand N, Perhach JL, Diamantis W, Sofia RD. Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases. Agents Actions 1985;17:407-17.
9. Pearce FL. Calcium and mast cell activation. Br J Clin Pharmacol 1985;20:267S-74S.
10. Morel DR, Zapol WM, Thomas SJ. C5a and thromboxane generation associated with pulmonary vaso- and bronchoconstriction during protamine reversal of heparin. Anesthesiology 1987;66:597-604.
11. Levy JH, Schwieger IM, Zaidan JR, Faraj BA, Weintraub WS. Evaluation of patients at risk for protamine reactions. J Thorac Cardiovasc Surg 1989;98:200-4.
12. Levy JH, Zaidan JR, Faraj BA. Prospective evaluation of risk of protamine reactions in NPH insulin-dependent diabetics. Anesth Analg 1986;65:739-42.
13. Lowenstein E, Johnston WE, Lappas DG, et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 1983;59:470-3.
14. Weiss ME, Nyhan D, Peng Z, et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 1989;320:886-92.
15. Sharath MD, Metzger WJ, Richersen HB, et al. Protamine induced fatal anaphylaxis. J Thorac Cardiovasc Surg 1985;90: 86-90.
16. Levi R, Laparter B, Alsaka K, Gross SS, Griggith O. Role of endothelium-derived nitric oxide in cardiac and systemic anaphylaxis. Circulation 1990;82:345.
17. Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth 1992;6:76-100.
18. Kreil E, Montalescot G, Greene E, et al. Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions. J Appl Physiol 1989;67:1463-71.
19. Morel DR, Lowenstein E, Nguyenduy T, et al. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation. Circ Res 1988;62: 905-15.
20. Nuttall GA, Murray MJ, Bowie EJ. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 1991;74:138-45.
21. Hobbhahn J, Conzen PF, Zenker B, Goetz AE, Peter K, Brendel W. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine. Anesth Analg 1988;67:253-60.
22. Montalescot G, Zapol WM, Carvalho A, Robinson DR, Torres A, Lowenstein E. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep [Comment]. Circulation 1990;82:1754-64.
23. Conzen PF, Habazettl H, Gutmann R, et al. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Anesth Analg 1989;68: 25-31.
24. Levy JH, Blister NW, Shear WA. Wheal and flare responses to opioids. Anesthesiology 1989;70:756-60.